Technological Advancements Driving Packaged AC Market Growth at 1.5% CAGR
Published: Jan 2026
Packaged AC system market was valued at $81.5 billion in 2025 and is projected to reach $94.3 billion by 2035, growing at a CAGR of 1.5% during the forecast period (2026-2035). The Global Packaged AC Systems Market is being accelerated by multiple factors, including the rapid expansion of commercial and industrial infrastructure, rising urbanization and increasing awareness of energy efficiency.
Global Sports Nutrition Market to Reach $78.7 billion by 2035, Driven by Rising Health Awareness and Active Lifestyles
Published: Jan 2026
Global sports nutrition market was valued at $45.7 billion in 2024 and is projected to reach $78.7 billion by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The global sports nutrition market is experiencing sustained growth, driven by increasing health consciousness, rising participation in fitness and sports activities, and growing demand for performance-enhancing nutritional products. Consumers across both professional and recreational segments are increasingly incorporating sports nutrition products into their daily routines to support energy, endurance, muscle recovery, and overall wellness.
Technological Advancements Driving 8.9% CAGR Growth in the Molecular Diagnostics Market
Published: Jan 2026
Molecular diagnostics market was valued at $19.2 billion in 2025 and is projected to reach $48.0 billion by 2035, growing at a CAGR of 8.9% during the forecast period (2026-2035). The molecular diagnostics market is expanding due to the growing prevalence of infectious and chronic diseases, rising demand for early diagnosis, and increasing adoption of personalized and point-of-care testing. But technological advancement is the key growth driver, with innovations in PCR, liquid biopsy, next-generation sequencing, and AI, it is significantly enhancing diagnostic accuracy, speed, and clinical value.
Rivastigmine Transdermal Patches Market to Reach $1,869.9 Million by 2035, Driven by Neurodegenerative Disease Growth
Published: Jan 2026
Global rivastigmine transdermal patches market was valued at $882.5 million in 2025 and is expected to reach $1,869.9 million by 2035, expanding at a CAGR of 7.9% over the forecast period from 2026 to 2035. The expanding burden of neurodegenerative diseases, led by Alzheimer’s disease, represents a key demand driver for the market. It directly enlarges the long-term treated population requiring cholinesterase inhibitor therapy. CDC estimates 6.7 million older adults in the US live with Alzheimer’s disease and projects this figure will rise to nearly 14 million by 2060, indicating a sustained expansion in diagnosis and ongoing management needs over the forecast horizon.
Global Respiratory Drugs and Devices Market Reaches $55.4 Billion in 2025 with Steady 4.2% Growth
Published: Jan 2026
Global respiratory drugs and devices market was valued at $55.4 billion in 2025 and is growing at a CAGR of 4.2% during the forecast period (2026-2035). Rising prevalence of chronic respiratory diseases, including asthma and COPD, increases the demand for long-term pharmacological treatments and supportive respiratory devices, driving market growth. As per the World Health Organization (WHO) Org., in June 2025,
Ingestible Sensors Market to Reach $2.17 Billion by 2035 Driven by AI Integration
Published: Jan 2026
Ingestible sensors market was valued at $987.3 million in 2024 and is projected to reach $2,174.8 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035).The ingestible sensors market is gaining momentum due to rising demand for non-invasive diagnostics, real-time patient monitoring, improved medication adherence, and the growing shift toward personalized and remote healthcare. Among these drivers, artificial intelligence (AI) integration stands out as the strongest growth catalyst, as it transforms ingestible sensors from passive data-collecting devices into intelligent systems capable of real-time analysis, predictive insights, and clinically actionable decision support.
Pigmented Villonodular Synovitis Drug Market to Reach $53.2 Million by 2035, Driven by Targeted Therapy Adoption
Published: Jan 2026
Pigmented villonodular synovitis drug market was valued at $42.8 million in 2025 and is projected to reach $53.2 million by 2035, growing at a CAGR of 2.2% during the forecast period (2026-2035). The limited feasibility of surgery and the growing need for effective systemic therapies is a major driver shaping the pigmented villonodular synovitis (PVNS) drug market, particularly within the diffuse and recurrent disease population. PVNS, also classified under tenosynovial giant cell tumors (TGCTs), is a rare however locally aggressive condition that primarily affects large joints and leads to progressive pain, swelling, and functional impairment.
Personal Care Appliances Market to reach $42.7 billion by 2035, driven by Personal Hygiene And Appearance
Published: Jan 2026
Global personal care appliances market was valued at $23.4 billion in 2024 and is projected to reach $42.7 billion by 2035, growing at a CAGR of 5.7% during the forecast period (2025-2035). The global personal care appliances market is experiencing robust growth as consumer demand for convenient, high-performance grooming and wellness devices increases. Rising awareness of personal hygiene and appearance, coupled with evolving lifestyle preferences, is encouraging the adoption of advanced appliances such as hair stylers, shavers, oral care devices, and skincare tools.
Global Omega-3 PUFA Market Set to Hit $2.0 Billion by 2025 with Robust 6.0% CAGR
Published: Jan 2026
Global omega-3 polyunsaturated fatty acids market was valued at $2.0 billion in 2025 and is growing at a CAGR of 6.0% during the forecast period (2026-2035). Dietary supplements play a significant role in providing omega-3 polyunsaturated fatty acids, especially for individuals with limited intake of fatty fish or plant-based omega-3 sources. These supplements commonly contain eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alpha-linolenic acid (ALA), which support normal physiological functions such as cardiovascular health, brain function, and inflammatory regulation.
Global Myotonic Dystrophy Drug Market to Reach $220.96 Million by 2035, Driven by Improved Diagnosis
Published: Jan 2026
global myotonic dystrophy drug market was valued at $110.3 million in 2025 and is projected to reach $220.96 million by 2035, growing at a CAGR of 7.2% during the forecast period (2026-2035). Improved disease recognition and genetic confirmation a major driver supporting the expansion of the myotonic dystrophy drug market. It increases the identifiable and treatable patient pool across neurology, cardiology, and respiratory care settings. Public health sources indicate that myotonic dystrophy affects about 10 in 100,000 people of all ages, indicating a meaningful prevalence base for long-term pharmacologic management.